Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative <i>Escherichia coli</i> Is ≤16 mg/L

• Main Authors: Yeonjae Kim (Author), Bongyoung Kim (Author), Seong Heon Wie (Author), Jieun Kim (Author), Moran Ki (Author), Yong Kyun Cho (Author), Seung Kwan Lim (Author), Jin Seo Lee (Author), Ki Tae Kwon (Author), Hyuck Lee (Author), Hee Jin Cheong (Author), Dae Won Park (Author), Seong Yeol Ryu (Author), Moon Hyun Chung (Author), Hyunjoo Pai (Author)
• Format: Book
• Published: MDPI AG, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The purpose of this study was to determine whether the fluoroquinolone (FQ) minimum inhibitory concentration (MIC) for the causative agent <i>Escherichia coli</i> influences the clinical response of FQ treatment at 72 h in patients with community-acquired acute pyelonephritis (CA-APN). W...